We are live on ! Find out more
SPRB

Spruce Biosciences
SPRB

38 hedge funds and large institutions have $72M invested in Spruce Biosciences in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

5% more capital invested

Capital invested by funds: $68.7M → $72M (+$3.25M)

0% more funds holding

Funds holding: 38 → 38 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
1
Increased
10
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
+$580K
2
Verition Fund Management
Verition Fund Management
Connecticut
+$530K
3
ACM
AIGH Capital Management
Maryland
+$225K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$149K
5
WVP
Worth Venture Partners
New Jersey
+$54.9K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$993K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$323K
3
Two Sigma Investments
Two Sigma Investments
New York
-$182K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$113K
5
Renaissance Technologies
Renaissance Technologies
New York
-$70.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$140K +$7.25K +43 +5%
SI
27
Sofinnova Investments
California
$131K – – –
MAM
28
Marquette Asset Management
Minnesota
$126K – – –
Northern Trust
29
Northern Trust
Illinois
$110K -$18.9K -112 -15%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$73.3K – – –
PFMU
31
Privium Fund Management (UK)
United Kingdom
$54.8K – – –
Charles Schwab
32
Charles Schwab
California
$34.6K – – –
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$22K +$16K +95 +279%
TRCT
34
Tower Research Capital (TRC)
New York
$9.85K +$4.55K +27 +87%
Morgan Stanley
35
Morgan Stanley
New York
$4.82K – – –
CSC
36
Caldwell Sutter Capital
California
$2.26K – – –
Bank of America
37
Bank of America
North Carolina
$701 +$674 +4 New
Wells Fargo
38
Wells Fargo
California
$294 – – –
Fidelity Investments
39
Fidelity Investments
Massachusetts
$82 – – –
UBS Group
40
UBS Group
Switzerland
$29 – – –
JP Morgan Chase
41
JP Morgan Chase
New York
$25 -$52.9K -314 Closed
1
2

SPRB Hedge Fund Activity: Q3 2023 in Review

38 of the 6,304 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q3 2023, worth a combined $72M — up 4.7% from $68.7M a quarter earlier.

Fund positioning in SPRB was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 10 added to existing stakes and 8 trimmed.

The largest buyer was DAFNA Capital Management, adding an estimated $580K. The largest seller was Armistice Capital, cutting an estimated $993K.

  • 38 institutional investors held Spruce Biosciences (SPRB) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $72M of Spruce Biosciences stock for Q3 2023, up 4.7% quarter-over-quarter.
  • 1 fund opened new Spruce Biosciences positions in Q3 2023 and 1 closed out, a net change of 0 holders.
  • The largest Spruce Biosciences buyer in Q3 2023 was DAFNA Capital Management, an estimated $580K added.
  • The largest Spruce Biosciences seller in Q3 2023 was Armistice Capital, an estimated $993K sold.

Based on aggregated 13F filings for Q3 2023.